Search Results - "Stavropoulos, Konstantinos"

Renal tubular transport protein regulation in primary aldosteronism: can large-scale proteomic analysis offer a new insight? by Stavropoulos, Konstantinos, Kassimatis, Efstratios, Doumas, Michael, Sarafidis, Pantelis

Get full text

COVID19 and increased mortality in African Americans: socioeconomic differences or does the renin angiotensin system also contribute? by Doumas, Michael, Patoulias, Dimitrios, Katsimardou, Alexandra, Stavropoulos, Konstantinos, Imprialos, Konstantinos, Karagiannis, Asterios

Get full text

Renin-Angiotensin System Inhibitors and COVID-19: a Systematic Review and Meta-Analysis. Evidence for Significant Geographical Disparities by Patoulias, Dimitrios, Katsimardou, Alexandra, Stavropoulos, Konstantinos, Imprialos, Konstantinos, Kalogirou, Maria-Styliani, Doumas, Michael

“…Purpose of Review While the COVID-19 pandemic is constantly evolving, it remains unclear whether the use of angiotensin-converting enzyme (ACE) inhibitors or…”
Get full text

Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk by Athyros, Vasilios G, Boutari, Chrysa, Stavropoulos, Konstantinos, Anagnostis, Panagiotis, Imprialos, Konstantinos P, Doumas, Michael, Karagiannis, Asterios

“…Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease (30% of the general population) and up to 40% of cases advance to the more severe…”
Get more information

Hypertension in Metabolic Syndrome: Novel Insights by Katsimardou, Alexandra, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Sachinidis, Alexandros, Doumas, Michalis, Athyros, Vasilios

“…Metabolic syndrome (MetS) is characterized by the simultaneous presence of obesity, hypertension, dyslipidemia and hyperglycemia in an individual, leading to…”
Get more information

Prognostic value of arterial stiffness measurements in cardiovascular disease, diabetes, and its complications: The potential role of sodium‐glucose co‐transporter‐2 inhibitors by Patoulias, Dimitrios, Papadopoulos, Christodoulos, Stavropoulos, Konstantinos, Zografou, Ioanna, Doumas, Michael, Karagiannis, Asterios

“…Type 2 diabetes mellitus (T2DM) constitutes a global pandemic, representing the 7th cause of death worldwide. Morbidity and mortality of patients with T2DM are…”
Get full text

Sexual Dysfunction, Cardiovascular Risk and Effects of Pharmacotherapy by Imprialos, Konstantinos P, Stavropoulos, Konstantinos, Doumas, Michael, Tziomalos, Konstantinos, Karagiannis, Asterios, Athyros, Vasilios G

“…Sexual dysfunction affects millions of people with an increasing prevalence, worldwide. The pathophysiology of the disease shares several similarities with…”
Get more information

Hypertension in Pregnancy: Unanswered Questions by Papademetriou, Vasilios, Stavropoulos, Konstantinos, Patoulias, Dimitrios, Papadopoulos, Christodoulos, Georgios, Kerpiniotis, Toumpourleka, Maria, Sachinidis, Alexandros

“…Hypertension of pregnancy [office blood pressure (BP) levels≥140/90 mmHg] is fairly common and can affect up to 10% of pregnant women worldwide. Hypertension…”
Get more information

Efficacy and safety of renal denervation for the management of arterial hypertension: A systematic review and meta‐analysis of randomized, sham‐controlled, catheter‐based trials by Stavropoulos, Konstantinos, Patoulias, Dimitrios, Imprialos, Konstantinos, Doumas, Michael, Katsimardou, Alexandra, Dimitriadis, Kyriakos, Tsioufis, Costas, Papademetriou, Vasilios

“…Despite the availability of a numerous antihypertensive agents, hypertension treatment and control rates remain low in many countries. The role of the…”
Get full text

SGLT-2 Inhibitors and Cardiovascular Risk in Diabetes Mellitus: A Comprehensive and Critical Review of the Literature by Imprialos, Konstantinos, Faselis, Charles, Boutari, Chrysoula, Stavropoulos, Konstantinos, Athyros, Vasilios, Karagiannis, Asterios, Doumas, Michael

“…Diabetes mellitus is a major cardiovascular risk factor. Despite the vast pharmaceutical armamentarium, current therapeutic options for the treatment of type 2…”
Get more information

Mineralocorticoid Receptor Antagonists in Primary Aldosteronism by Stavropoulos, Konstantinos, Papadopoulos, Christodoulos, Koutsampasopoulos, Konstantinos, Lales, Georgios, Mitas, Christos, Doumas, Michael

“…Primary aldosteronism is the most common causes of secondary hypertension. Patients suffering from this clinical syndrome have an increased cardiovascular risk…”
Get more information

Novel Drugs for Hypertension and Heart Failure: Struggling for a Place Under the Sun by Faselis, Charles, Boutari, Chrysoula, Doumas, Michael, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Kokkinos, Peter

“…Backgound: Current drug therapy for the management of arterial hypertension and heart failure has provided substantial benefits but has also some limitations…”
Get more information

Blood pressure and cardiovascular outcomes: a closer look by Doumas, Michael, Stavropoulos, Konstantinos V, Boutari, Chrysoula, Imprialos, Konstantinos P, Karagiannis, Asterios

“…[...]in a post-hoc analysis of 22 576 patients with hypertension and coronary artery disease,4 the risk cardiovascular events and death was significantly…”
Get full text

Mineralocorticoid Receptor Antagonists in Cardiovascular Medicine: Looking for the Forest Among the Trees by Stavropoulos, Konstantinos V, Imprialos, Konstantinos P, Doumas, Michael, Faselis, Charles J

Get more information

The Associations between Kidney Function and Sexual Dysfunction among Males and Females with Type 2 Diabetes Mellitus by Katsimardou, Alexandra, Patoulias, Dimitrios, Zografou, Ioanna, Tegou, Zoi, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Toumpourleka, Maria, Karagiannis, Asterios, Petidis, Konstantinos, Doumas, Michael

“…: Diabetic kidney disease (DKD), expressed either as albuminuria, low estimated glomerular filtration rate (eGFR) or both, and sexual dysfunction (SD), are…”
Get full text

Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis by Stavropoulos, Konstantinos, Imprialos, Konstantinos, Pittaras, Andreas, Faselis, Charles, Narayan, Puneet, Kokkinos, Peter

“…Non-alcoholic fatty liver disease (NAFLD) is one of the most common diseases worldwide, affecting more than 30% of general population. High-fat diets, physical…”
Get more information

A significant dilemma in the treatment of heart failure patients with sacubitril/valsartan or sodium-glucose co-transporter 2 inhibitors: Whether to add mineralocorticoid receptor antagonists by Patoulias, Dimitrios, Papadopoulos, Christodoulos, Stavropoulos, Konstantinos, Imprialos, Konstantinos, Boulmpou, Aristi, Doumas, Michael

Get full text

The Role of Mineralocorticoid Receptor Antagonists in Heart Failure with Reduced Ejection Fraction by Papademetriou, Vasilios, Toumpourleka, Maria, Imprialos, Konstantinos P, Alataki, Sofia, Manafis, Alexandros, Stavropoulos, Konstantinos

“…Heart failure (HF) is a worldwide modern epidemic, associated with significant morbidity and mortality. Several causes have been identified for the syndrome,…”
Get more information

Serum leptin in non-alcoholic fatty liver disease: Ambiguous clinical implications concerning cardiovascular disease by Patoulias, Dimitrios, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Doumas, Michael

“…A more recent observational study demonstrated that individuals with NAFLD exhibit a significantly higher risk of 10-year CVD incidence, further confirming…”
Get full text

What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? by Doumas, Michael, Imprialos, Konstantinos, Stavropoulos, Konstantinos, Athyros, Vasilios G

“…Non-Alcoholic Fatty Liver Disease (NAFLD), the most common liver disease, is characterized by accumulation of fat (>5% of the liver tissue), in the absence of…”
Get more information